SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-004251
Filing Date
2024-01-30
Accepted
2024-01-30 10:46:33
Documents
20
Period of Report
2024-01-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 48413
2 ex4-1.htm EX-4.1 127754
3 ex4-2.htm EX-4.2 123875
4 ex4-3.htm EX-4.3 126551
5 ex10-1.htm EX-10.1 254317
6 ex99-1.htm EX-99.1 13245
7 ex99-1_001.jpg GRAPHIC 11977
  Complete submission text file 0001493152-24-004251.txt   1029316

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE pcsa-20240126.xsd EX-101.SCH 3060
9 XBRL LABEL FILE pcsa-20240126_lab.xml EX-101.LAB 34240
10 XBRL PRESENTATION FILE pcsa-20240126_pre.xml EX-101.PRE 22389
21 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3618
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39531 | Film No.: 24576356
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)